Skip to search.
 TSX Up 0.21% TSX Ventures Up 1.43%

Geron Corporation (GERN)

-NasdaqGS
2.68 Up 0.02(0.75%) Jul 29, 4:00PM EDT
|After Hours : 2.68 Up 0.00 (0.02%) Jul 29, 4:48PM EDT
Prev Close:2.66
Open:2.66
Bid:2.68 x 1800
Ask:2.81 x 100
1y Target Est:7.50
Beta:3.29779
Next Earnings Date: 3-Aug-16GERN Earnings announcement
Day's Range:2.64 - 2.70
52wk Range:2.30 - 5.30
Volume:802,691
Avg Vol (3m):1,679,770
Market Cap:426.01M
P/E (ttm):893.33
EPS (ttm):0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNUp 0.75%426.01M
BMYUp 0.20%124.88B
GSKDown 0.24%109.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.26
Quarterly EPS Est (Jun-16) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-2.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback